Does the anti-herpesviral effect of leflunomide play a role in the treatment of rheumatoid arthritis?
H V
HV
Valleala
L M
LM
Virkki
Y T
YT
Konttinen
D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D003587:Cytomegalovirus / Q000187:drug effects / Q000235:genetics; D004279:DNA, Viral / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000235:genetics; D006801:Humans; D007555:Isoxazoles / Q000494:pharmacology / Q000627:therapeutic use*; D000077339:Leflunomide; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D019562:Viral Load / Q000187:drug effects
D018501:Antirheumatic Agents; D000998:Antiviral Agents; D004279:DNA, Viral; D007555:Isoxazoles; D000077339:Leflunomide